Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: MTMCT CRISPR-Cas9 screening

PROVIDER: PRJNA1255442 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR33312900_1.fastq.gz	Fastqsanger.gz
	SRR33312900_2.fastq.gz	Fastqsanger.gz
	SRR33312901_1.fastq.gz	Fastqsanger.gz
	SRR33312901_2.fastq.gz	Fastqsanger.gz
	SRR33312902_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 28

Similar Datasets

Genotyping of C.elegans mutants - CRISPR/Cas9 of all GPCR and neuropeptide genes

Project description:CRISPR/Cas9 genome editing was used to disrupt nearly all the GPCR and neuropeptide genes from C. elegans genome. Multiple genes were disrupted in each strain for the purpose of screening. The genotype is the list of targeted genes

2023-06-02 | E-MTAB-12983 | biostudies-arrayexpress

E-MTAB-9018

Project description:RNA-Seq of wild type and somatostatin 3 CrispR/Cas9 zebrafish mutants treated with dextran sodium sulfate (DSS)

2023-06-16 | E-MTAB-9018 | ExpressionAtlas

E-MTAB-6241

Project description:RNA-seq expression profiling of OCI-AML2 and OCI-AML3 cells upon CRISPR/Cas9 mediated disruption of DDX3X RNA binding domain

2025-01-23 | E-MTAB-6241 | ExpressionAtlas

CRISPR Screening in Glioblastoma

Project description:This is an in vitro genome-wide CRISPR/cas9 screen in human glioblastoma stem cells, screening for genes essential for survival of these cells. These cells express cas9 and have been transfected with a guide RNA library causing gene knockouts. We will analyse the sequencing data for depletion of guide RNAs. In this particular study, we will do RNA sequencing to correlate CRISPR with expression levels in specific cancer cell subpopulations. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria), please see http://www.sanger.ac.uk/datasharing/

2016-03-22 | E-ERAD-448 | biostudies-arrayexpress

CRISPR_RSL

Project description:CRISPR/Cas9 screening using unique molecular identifiers

| PRJEB18436 | ENA

Project description:CRISPR/Cas9-based Drug Target Screening Library

| PRJNA1119749 | ENA

Project description:CRISPR/Cas9 m6A metabolic enzyme knockout screening

| PRJNA1077874 | ENA

Cross-species screening platforms identify EPS-8 as a critical link for mitochondrial stress and actin stabilization.

Project description:1) CRISPR-Cas9 screening of 3.5ng/mL rotenone-treated NPCs versus an ethanol control (treatments include 8 days and 23 days of treatment). 2) RNA-sequencing of NPCs treated with 10µg/mL antimycin A for 8 hours compared to an ethanol control 3) RNA-sequencing of whole C. elegans grown on empty-vector control or fed eps-8 RNAi

2021-12-01 | E-MTAB-10843 | biostudies-arrayexpress

Genome-wide identification of CRISPR/Cas9 off-targets in human genome

Project description:By a robust unbiased ChIP-seq approach, we demonstrated that CRISPR/Cas9 had crRNA-specific off-target binding activities in human genome. However, most of those binding off-targets could not be efficiently cleaved both in vivo and in vitro which suggested the cleavage off-target activity of CRISPR/Cas9 in human genome is very limited. We provided a valuable tool to further investigate the molecular mechanism of CRISPR/Cas9 and to optimize its in vivo targeting sgRNA binding sites were identified with ChipSeq by using GFP antibody (there are 2 replicates for egfa-t1 sgRNA,emx1 sgRNA and control without sgRNA in Hek293T cells, one egfa-t1 sgRNA,emx1 sgRNA and control without sgRNA in HeLaS3 cells)

2014-06-18 | E-GEOD-58511 | biostudies-arrayexpress

rRNA 2'-O-methylation profile of SNORD71 knockdown cells

Project description:We generated a SNORD71 KO chondrocyte cell pool using CRISPR/Cas9 gene editing. A CRISPR control cell line was generated and used as a control. Levels of 2’-O-methylation of human rRNAs in SNORD71 KO cell pool and CRISPR control cells were evaluated by RiboMethSeq.

2022-03-05 | E-MTAB-11470 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data